{"product_id":"osler-radiation-oncology-2021","title":"Osler Radiation Oncology 2021 Online Review","description":"\u003ch2\u003eOsler Radiation Oncology 2021 Online Review\u003c\/h2\u003e\u003cbr\u003eThe Osler Institute utilized state-of-the-art equipment to record our Live Virtual Webinar March 2021 comprehensive Radiation Oncology Review Course and bring it to you! these Video files are stored “in the cloud” so you can stream them anywhere, anytime, as long as you have an internet connection, watch or listen to on your phone, computer, or tablet – your learning experience is almost like being at the live activity, but without travel costs and time away from your practice. Included with each online review is a downloadable copy of the syllabus that corresponds to the Video lectures for your use while viewing or as a free-standing study or clinical practice guide.\u003cbr\u003e\u003cbr\u003eThis review provides senior trainees and\/or clinicians in practice a comprehensive update of clinical knowledge and helps prepare them for their Radiation Oncology exams (the initial certification and MOC). Emphasis is on evidence-based medicine and board-relevant standards of care as well as new concepts, treatments, and imaging approaches. The written exams emphasize anatomy, epidemiology, etiological agents, natural history, pathology, tumor markers, initial clinical evaluation, staging, routes of spread, selection of treatment modality and techniques, surgical and chemotherapy adjuvant treatments, follow-up treatment and evaluation, patterns of failure, and normal tissue effects including complications; all of these areas are addressed. The review also covers the basic principles of radiobiology and physics that are relevant to clinical practice.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eObjectives\u003c\/strong\u003e\u003cbr\u003eAt the conclusion of this course, each participant should be able to perform the following tasks for all cancers of the eleven ABR defined component areas:\u003cbr\u003e- Describe the anatomy, epidemiology\/etiologic agents, and natural history\u003cbr\u003e- Explain the pathology and use of tumor markers\u003cbr\u003e- Describe the initial clinical evaluation, staging, and routes of disease spread (local and distant)\u003cbr\u003e- Summarize potential treatment modalities including optimum beam and radiation sources, volume and dose calculations, as well as fractionation\u003cbr\u003e- Discuss follow-up treatment and evaluation, patterns of failure, and normal tissue effects\u003cbr\u003e- Discuss the use of multimodality therapies, including sequence, interactions, and specific agents\u003cbr\u003e- Describe brachytherapy applications and issues for all disease sites\u003cbr\u003e- Outline the use of palliative care for brain, hepatic and skeletal lesions, plus various obstructive scenarios\u003cbr\u003e- Implement a basic program of ethics, patient safety, and quality assurance in clinical practice\u003cbr\u003e\u003ch3 class=\"yikes-custom-woo-tab-title yikes-custom-woo-tab-title-faculty-and-topics\"\u003e\u003cstrong\u003eFaculty and Topics\u003c\/strong\u003e\u003c\/h3\u003e\n\u003ch2\u003e\n\u003cimg alt=\"\" class=\"wp-image-74543 size-thumbnail alignleft entered error\" data-lazy-src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2021\/03\/FAC_ROC_D_Blakaj-131x150.jpg\" data-ll-status=\"error\" height=\"150\" src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2021\/03\/FAC_ROC_D_Blakaj-131x150.jpg\" width=\"131\"\u003eDukagjin Blakaj, MD, Ph.D.\u003cbr\u003eAssistant Professor of Radiation Oncology,\u003cbr\u003eOhio State University\u003c\/h2\u003e\u003cbr\u003eHead and Neck Cancer I – III\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003ch2\u003e\n\u003cimg alt=\"\" class=\"alignleft size-thumbnail wp-image-47417 entered error\" data-lazy-src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2018\/03\/FAC_ROC_S_Lin-150x150.png\" data-ll-status=\"error\" height=\"150\" src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2018\/03\/FAC_ROC_S_Lin-150x150.png\" width=\"150\"\u003eSteven Lin, MD, Ph.D.\u003cbr\u003eAssociate Professor of Radiation Oncology,\u003cbr\u003eMD Anderson Cancer Center\u003c\/h2\u003e\u003cbr\u003eEarly Stage NSCLC, Locally Advanced NSCLC, Small Cell Lung Cancer, Rare Mediastinal Tumors\u003cbr\u003e\u003ch2\u003e\n\u003cimg alt=\"\" class=\"alignleft size-thumbnail wp-image-43148 entered error\" data-lazy-src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2017\/04\/FAC_ROC_V_Mangona-150x150.png\" data-ll-status=\"error\" height=\"150\" src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2017\/04\/FAC_ROC_V_Mangona-150x150.png\" width=\"150\"\u003eVictor Mangona, MD\u003cbr\u003ePracticing Radiation Oncologist, Texas Center for Proton Therapy, Irvine, TX\u003c\/h2\u003e\u003cbr\u003ePediatric Brain Tumors, Brain Stem Glioma, Medulloblastoma, Intracranial Germ Cell Tumors, Ependymoma, Pediatric Gliomas, Pediatric CNS Questions, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Ewing’s Sarcoma, Pediatric Solid Questions\u003cbr\u003e\u003ch2\u003e\n\u003cimg alt=\"\" class=\"alignleft size-thumbnail wp-image-42901 entered error\" data-lazy-src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2016\/12\/FAC_ROC_T_Swanson-150x150.png\" data-ll-status=\"error\" height=\"150\" src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2016\/12\/FAC_ROC_T_Swanson-150x150.png\" width=\"150\"\u003eTodd Swanson, MD, PhD†\u003cbr\u003eAssistant Professor of Radiation Oncology, University of Texas, Galveston\u003c\/h2\u003e\u003cbr\u003eCNS Overview, Primary CNS Malignancies, CNS Metastasis of Brain, CNS Metastasis Spine, Benign disorders of CNS, Palliative Care, †Course Planning Committee\u003cbr\u003e\u003ch2\u003e\n\u003cimg alt=\"\" class=\"size-thumbnail wp-image-74542 alignleft entered error\" data-lazy-src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2021\/03\/FAC_ROC_C_Tang-131x150.jpg\" data-ll-status=\"error\" height=\"150\" src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2021\/03\/FAC_ROC_C_Tang-131x150.jpg\" width=\"131\"\u003eChad Tang, MD\u003cbr\u003eAssistant Professor\u003cbr\u003eRadiation Oncology\u003cbr\u003eInvestigational Cancer Therapeutics Translational Molecular Pathology\u003c\/h2\u003e\u003cbr\u003eEarly\/Intermediate-Risk Prostate Cancer, High Risk and Metastatic Prostate Cancer, Adjuvant\/Salvage Prostate Cancer\u003cbr\u003e\u003ch2\u003e\n\u003cimg alt=\"\" class=\"size-thumbnail wp-image-74545 alignleft entered error\" data-lazy-src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2021\/03\/FAC_ROC_J_Gunther-131x150.jpg\" data-ll-status=\"error\" height=\"150\" src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2021\/03\/FAC_ROC_J_Gunther-131x150.jpg\" width=\"131\"\u003eJillian R. Gunther, MD PhD\u003cbr\u003eAssistant Professor\u003cbr\u003eThe University of Texas\u003cbr\u003eMD Anderson Cancer Center\u003c\/h2\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003eHodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, and Solitary Plasmacytoma\u003cbr\u003e\u003ch2\u003e\n\u003cimg alt=\"\" class=\"size-thumbnail wp-image-74546 alignleft entered error\" data-lazy-src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2021\/03\/FAC_ROC_S_Silva-131x150.jpg\" data-ll-status=\"error\" height=\"150\" src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2021\/03\/FAC_ROC_S_Silva-131x150.jpg\" width=\"131\"\u003e\u003cbr\u003eScott R. Silva MD, Ph.D.\u003cbr\u003eAssistant Professor\u003cbr\u003eUniversity of Louisville\u003cbr\u003eSchool of Medicine\u003c\/h2\u003e\u003cbr\u003eEndometrial Cancer, Cervical Cancer, Vulvar Cancer\u003cbr\u003e\u003ch2\u003e\n\u003cimg alt=\"\" class=\"size-thumbnail wp-image-74544 alignleft entered error\" data-lazy-src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2021\/03\/FAC_ROC_T_Thomas-131x150.jpg\" data-ll-status=\"error\" height=\"150\" src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2021\/03\/FAC_ROC_T_Thomas-131x150.jpg\" width=\"131\"\u003e\u003cbr\u003eTarita Thomas, MD, Ph.D., MBA\u003c\/h2\u003e\u003cbr\u003eEarly Stage Breast Cancer, Locally Advanced Breast Cancer, Carcinoma-in-situ and Misc (DCIS)\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003ch2\u003e\n\u003cimg alt=\"\" class=\"size-thumbnail wp-image-74540 alignleft entered error\" data-lazy-src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2021\/03\/FAC_ROC_N_Hanna-131x150.jpg\" data-ll-status=\"error\" height=\"150\" src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2021\/03\/FAC_ROC_N_Hanna-131x150.jpg\" width=\"131\"\u003e\u003cbr\u003eNavine Hanna, MD, MPH\u003cbr\u003eRadiation Oncology Specialists Advent Health Medical Group\u003cbr\u003ePalm Coast, FL\u003c\/h2\u003e\u003cbr\u003eEsophageal Cancer, Gastric Cancer, Colon Cancer, Rectal Cancer, Anal Cancer, Liver Cancer, Pancreatic Ampullary Cancer, Bile Duct Cancer\u003cbr\u003e\u003ch2\u003e\n\u003cimg alt=\"\" class=\"size-thumbnail wp-image-74090 alignleft entered error\" data-lazy-src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2021\/03\/FAC_PED_P_Khandhar-131x150.jpg\" data-ll-status=\"error\" height=\"150\" src=\"https:\/\/www.osler.org\/wp-content\/uploads\/2021\/03\/FAC_PED_P_Khandhar-131x150.jpg\" width=\"131\"\u003eParas Khandhar, MD, FAAP\u003cbr\u003eAttending, Pediatric Critical Care Medicine, Beaumont Children’s\u003cbr\u003eLead Inpatient Physician Informaticist – Beaumont Health\u003cbr\u003eAssociate Professor of Pediatrics, Oakland University William Beaumont School of Medicine\u003c\/h2\u003e\u003cbr\u003eEVIDENCED BASED MEDICINE (EBM), PATIENT SAFETY \u0026amp; QUALITY IMPROVEMENT\u003cbr\u003e\u003cbr\u003e ","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954301505634,"sku":"MED-AMB00734","price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/pd_roc_oslerolr.png?v=1779370604","url":"https:\/\/meducourse.com\/products\/osler-radiation-oncology-2021","provider":"Meducourse","version":"1.0","type":"link"}